If we're almost at 180, pull the data and examine

Quote:

---

If we're almost at 180, pull the data and examine it. Why wait for 195 when the need is so urgent?

Read More: https://investorshangout.com/post/newpost/605...z6UMx1N1pN

---

Great question. I think the FDA should assign one person to watch each trial and see the unblinded data as we go, and report back. All that are promising should be fastracked. It really is hard to understand.